A Pharmaceutics Primer on Slow Release Drugs

You’ve likely encountered these questions before - or are likely to in the future. And you probably remember the simple answers:

Immediate release can be crushed. Sustained/delayed/extended release cannot.

Of course, we can’t really stop there and still call ourselves pharmacists, can we? The answer is much more nuanced and complex. Are there exceptions to the above mantra? Yes. Are there blanket rules of thumb? Also, yes.

So let’s dive in and explore further…

Immediate vs. Delayed vs. Extended Release Formulations

Finding the answers to formulation questions isn’t easy. If you’re like most of us, you start by fumbling through the package insert to see if there are any instructions on crushing the tablet or opening the capsule in the “Dosage and Administration” section. I mean, if anyone has that knowledge, it should be the manufacturer, right?!

Or maybe you do a quick Google search to see if anything relevant comes up. But can you trust Dr. Google?

And what about the “exceptions?” What makes one ER tablet okay to crush when it’s a huge no-no for another?

Ready to have your mind blown?

You’ve most likely been taught the answer to this riddle already. If only you paid attention during that one pharmaceutics class in pharmacy school, when we learned about coatings and additives for making a drug delayed or extended…

But, let’s be honest, most of us sat in the back row and alternated ‘studying’ Facebook with staring out the window. The pharmaceutical difference between ER vs DR vs IR is the ghost of a memory…something you (barely) retained for an exam and then promptly forgot it.

This post will (hopefully) help to dust the cobwebs off of those dark, dank corners of your brain.

Before we go any further, lets clarify something. According to the United States Pharmacopeia (USP) nomenclature guidelines, there are two terms for ‘modified release’:

The USP also includes examples of when to call your drug Delayed versus Extended.

Whoop dee do, right? Doesn’t exactly seem sufficient to cover all the bases.

In addition, USP also recommends terms for dosage forms when it comes to describing products, which is handy particularly now considering all the chat surrounding aerosolized medications.